Julie Papanek Grant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., and Protagonist Therapeutics, Inc.

2016 was Julie Papanek Grant's most active year for acquiring shares with 1 total transactions. Julie Papanek Grant's most active month to acquire stocks was the month of April. 2021 saw Julie Papanek Grant paying a total of $0.00 for 63,000 shares, this is the most they've acquired in one year.